RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 15.60
+1.10 (7.59%)
Jan 23, 2026, 3:37 PM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 9.62 million as of January 23, 2026. Its market cap has increased by 29.17% in one year.
Market Cap
9.62M
Enterprise Value
7.18M
Revenue
4.11M
Ranking
n/a
PE Ratio
9,619.34
Stock Price
15.60
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 9.62M, a decrease of -59.62%. That is a compound annual growth rate of -3.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 9.62M | 10.71% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.68B |
| GSK plc | 72.04B |
| Haleon | 33.21B |
| Smith & Nephew | 10.20B |
| Verici Dx | 10.97M |
| IXICO | 10.66M |
| Genflow Biosciences | 9.62M |
| Proteome Sciences | 8.41M |